Free Trial

Enovix (NASDAQ:ENVX) Stock Price Up 1.3% - Here's What Happened

Enovix logo with Energy background

Enovix Corporation (NASDAQ:ENVX - Get Free Report) shares were up 1.3% during mid-day trading on Wednesday . The company traded as high as $15.02 and last traded at $14.88. Approximately 2,650,931 shares changed hands during trading, a decline of 62% from the average daily volume of 6,977,700 shares. The stock had previously closed at $14.69.

Analyst Ratings Changes

A number of analysts have recently issued reports on ENVX shares. JPMorgan Chase & Co. reissued a "neutral" rating and set a $12.00 target price (up from $9.00) on shares of Enovix in a research note on Thursday. Wall Street Zen raised shares of Enovix from a "sell" rating to a "hold" rating in a research note on Saturday, July 12th. Benchmark lifted their price objective on Enovix from $15.00 to $25.00 and gave the company a "buy" rating in a report on Friday. B. Riley restated a "buy" rating and issued a $17.00 price objective (up from $12.00) on shares of Enovix in a report on Thursday, July 10th. Finally, TD Securities decreased their price objective on Enovix from $10.00 to $7.00 and set a "hold" rating for the company in a report on Thursday, May 1st. Six equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Enovix currently has a consensus rating of "Moderate Buy" and a consensus target price of $18.73.

Get Our Latest Stock Analysis on Enovix

Enovix Trading Up 1.8%

The stock has a market capitalization of $2.82 billion, a price-to-earnings ratio of -11.39 and a beta of 2.09. The company has a 50 day moving average of $10.43 and a 200 day moving average of $9.31. The company has a debt-to-equity ratio of 0.71, a quick ratio of 4.49 and a current ratio of 4.68.

Enovix announced that its Board of Directors has initiated a share repurchase program on Wednesday, July 2nd that allows the company to buyback $60.00 million in shares. This buyback authorization allows the company to purchase up to 3.1% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's management believes its shares are undervalued.

Hedge Funds Weigh In On Enovix

A number of hedge funds and other institutional investors have recently bought and sold shares of ENVX. Vanguard Group Inc. boosted its holdings in Enovix by 15.1% during the 4th quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company's stock valued at $171,458,000 after acquiring an additional 2,063,631 shares during the period. Kingstone Capital Partners Texas LLC purchased a new position in shares of Enovix in the 2nd quarter valued at about $13,206,000. Fred Alger Management LLC boosted its stake in shares of Enovix by 212.4% in the 4th quarter. Fred Alger Management LLC now owns 1,838,914 shares of the company's stock valued at $19,989,000 after buying an additional 1,250,300 shares during the period. Electron Capital Partners LLC boosted its stake in shares of Enovix by 18.6% in the 1st quarter. Electron Capital Partners LLC now owns 6,712,763 shares of the company's stock valued at $49,272,000 after buying an additional 1,054,029 shares during the period. Finally, CenterBook Partners LP boosted its stake in shares of Enovix by 71.0% in the 1st quarter. CenterBook Partners LP now owns 1,736,570 shares of the company's stock valued at $12,746,000 after buying an additional 721,309 shares during the period. 50.92% of the stock is currently owned by hedge funds and other institutional investors.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Articles

Should You Invest $1,000 in Enovix Right Now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines